Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway. - Li L; Zheng BB; Ma LS; Sun X; Chang JJ; Xie WD; Li X (Acta pharmacologica Sinica, 2014)